Your browser is no longer supported. Please, upgrade your browser.
BIO Bio-Rad Laboratories, Inc. weekly Stock Chart
BIO [NYSE]
Bio-Rad Laboratories, Inc.
IndexS&P 500 P/E10.07 EPS (ttm)52.17 Insider Own1.70% Shs Outstand29.87M Perf Week-1.94%
Market Cap15.90B Forward P/E53.04 EPS next Y9.90 Insider Trans-0.38% Shs Float21.20M Perf Month12.35%
Income1.58B PEG0.57 EPS next Q1.60 Inst Own77.80% Short Float2.72% Perf Quarter14.07%
Sales2.33B P/S6.83 EPS this Y456.30% Inst Trans0.05% Short Ratio2.06 Perf Half Y40.34%
Book/sh210.72 P/B2.49 EPS next Y30.77% ROA22.30% Target Price536.25 Perf Year63.95%
Cash/sh34.24 P/C15.34 EPS next 5Y17.80% ROE31.00% 52W Range309.38 - 540.06 Perf YTD41.94%
Dividend- P/FCF44.25 EPS past 5Y80.40% ROI-4.50% 52W High-2.75% Beta1.12
Dividend %- Quick Ratio1.80 Sales past 5Y1.20% Gross Margin54.30% 52W Low69.77% ATR13.61
Employees8120 Current Ratio2.40 Sales Q/Q3.20% Oper. Margin9.60% RSI (14)61.47 Volatility2.70% 2.57%
OptionableYes Debt/Eq0.07 EPS Q/Q-21.00% Profit Margin75.50% Rel Volume0.47 Prev Close527.30
ShortableYes LT Debt/Eq0.00 EarningsJul 30 AMC Payout0.00% Avg Volume280.40K Price525.22
Recom1.50 SMA202.44% SMA509.34% SMA20029.57% Volume132,209 Change-0.39%
Jan-08-20Initiated Wells Fargo Overweight $430
Jan-07-20Initiated Citigroup Buy $450
Oct-17-18Initiated Goldman Buy $350
Sep-20-18Initiated Morgan Stanley Equal-Weight $335
Feb-16-18Downgrade CL King Buy → Neutral
Jul-13-17Initiated Wells Fargo Outperform
Jun-28-17Upgrade Deutsche Bank Hold → Buy $220 → $255
Jan-18-17Initiated Deutsche Bank Hold $195
Oct-13-16Initiated CL King Buy
May-06-15Reiterated Jefferies Buy $150 → $165
Dec-18-09Initiated Maxim Group Buy $125
Nov-06-09Initiated Jefferies & Co Buy $130
Jul-17-09Initiated Soleil Buy $91
Sep-26-07Initiated Banc of America Sec Buy $110
Feb-23-07Downgrade Robert W. Baird Outperform → Neutral $83 → $76
Aug-04-20 08:30AM  
Jul-31-20 08:33PM  
10:36AM  
Jul-30-20 05:45PM  
04:15PM  
Jul-29-20 09:16AM  
Jul-28-20 03:18PM  
Jul-27-20 08:29AM  
Jul-24-20 07:31PM  
Jul-23-20 12:32PM  
Jul-15-20 08:01PM  
Jul-13-20 08:12PM  
Jul-09-20 03:57PM  
09:32AM  
Jun-30-20 05:18PM  
10:40AM  
Jun-15-20 11:31AM  
Jun-12-20 06:18PM  
Jun-11-20 07:30PM  
06:00AM  
Jun-08-20 10:22AM  
Jun-05-20 10:00AM  
Jun-01-20 09:07AM  
May-15-20 03:06PM  
May-13-20 03:34PM  
May-12-20 11:51AM  
May-07-20 06:06PM  
10:11AM  
May-06-20 08:25PM  
04:15PM  
May-05-20 08:00AM  
May-04-20 07:27PM  
11:12AM  
May-03-20 03:37PM  
Apr-30-20 04:51PM  
09:00AM  
Apr-29-20 12:34PM  
Apr-27-20 08:00AM  
06:16AM  
Apr-23-20 06:44PM  
Apr-22-20 04:25PM  
Apr-21-20 10:35AM  
08:30AM  
Apr-09-20 09:35AM  
09:23AM  
08:30AM  
Apr-08-20 10:34AM  
06:57AM  
Apr-07-20 08:30AM  
Apr-06-20 01:55PM  
Apr-02-20 09:42AM  
Mar-31-20 08:00AM  
Mar-23-20 06:16PM  
11:16AM  
Mar-20-20 10:43AM  
07:00AM  
Mar-19-20 05:30PM  
07:37AM  
Mar-18-20 07:24PM  
Mar-17-20 11:27AM  
Mar-14-20 11:30AM  
Mar-13-20 09:45AM  
Mar-12-20 07:30PM  
Mar-09-20 01:30PM  
08:34AM  
Feb-25-20 04:15PM  
Feb-24-20 05:47PM  
Feb-18-20 06:31PM  
Feb-14-20 10:35AM  
08:53AM  
Feb-13-20 06:45PM  
06:23PM  
Feb-06-20 12:30PM  
Feb-04-20 07:00AM  
Feb-03-20 09:37PM  
Jan-09-20 05:40AM  
Jan-06-20 08:30AM  
Jan-02-20 04:15PM  
Dec-30-19 11:47AM  
Dec-25-19 02:35PM  
Dec-23-19 08:30AM  
Dec-13-19 04:52PM  
Dec-11-19 05:23AM  
Dec-02-19 08:40PM  
Nov-30-19 02:28PM  
Nov-26-19 12:11PM  
Nov-18-19 01:17AM  
Nov-11-19 07:49AM  
Nov-01-19 12:03PM  
Oct-31-19 06:15PM  
04:15PM  
Oct-29-19 05:09PM  
Oct-24-19 10:32AM  
Oct-23-19 11:13AM  
Oct-16-19 04:15PM  
Oct-15-19 12:05PM  
Oct-12-19 03:34PM  
Oct-08-19 10:36AM  
Oct-07-19 06:36AM  
Oct-02-19 09:48AM  
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHWARTZ NORMAN DChairman, President, and CEOJun 12Option Exercise84.5737,0003,129,090316,982Jun 15 07:02 PM
Crowley MichaelEVP, GBL Commercial OperationsJun 01Sale485.401,500728,1002,310Jun 02 05:11 PM
HUTTON RONALD WVice President and TreasurerMay 13Sale457.35443202,6064,140May 14 01:11 PM
Last Andrew J.EVP, Chief Operating OfficerApr 29Option Exercise0.001,00001,026Apr 30 02:14 PM
Daskal IlanEVP, Chief Financial OfficerApr 08Option Exercise0.007000700Apr 09 01:07 PM
ERNST TIMOTHY SEVP, General Counsel & SecDec 04Option Exercise159.321,250199,1502,362Dec 05 07:03 PM
ERNST TIMOTHY SEVP, General Counsel & SecDec 04Sale370.111,906705,436456Dec 05 07:03 PM
STARK JAMES RVP, Corporate ControllerNov 11Sale351.45848298,0300Nov 12 11:33 AM
HERTIA JOHNExecutive Vice PresidentSep 12Option Exercise129.551,200155,46019,566Sep 13 11:54 AM
TUMOLO ANNETTEExecutive Vice PresidentSep 12Sale330.00522172,2602,410Sep 16 06:05 PM
HERTIA JOHNExecutive Vice PresidentSep 12Sale328.29838275,10418,728Sep 13 11:54 AM
HERTIA JOHNExecutive Vice PresidentSep 11Option Exercise0.00600018,664Sep 13 11:48 AM
Crowley MichaelEVP, GBL Commercial OperationsSep 11Option Exercise0.0060004,041Sep 12 03:59 PM
HUTTON RONALD WVice President and TreasurerSep 11Option Exercise0.0015004,619Sep 12 04:12 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 11Option Exercise0.00500015,065Sep 12 04:15 PM
STARK JAMES RVP, Corporate ControllerSep 11Option Exercise0.003000952Sep 12 04:19 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 11Option Exercise0.003,2000281,529Sep 12 04:24 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 11Option Exercise0.0060003,170Sep 12 04:29 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 10Option Exercise0.0040002,709Sep 12 04:29 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 10Option Exercise0.002,0000279,321Sep 12 04:24 PM
STARK JAMES RVP, Corporate ControllerSep 10Option Exercise0.002000722Sep 12 04:19 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 10Option Exercise0.00400014,764Sep 12 04:15 PM
HUTTON RONALD WVice President and TreasurerSep 10Option Exercise0.0015004,521Sep 12 04:12 PM
HERTIA JOHNExecutive Vice PresidentSep 10Option Exercise0.00600018,362Sep 12 04:07 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 10Option Exercise0.0038903,576Sep 12 03:59 PM
HERTIA JOHNExecutive Vice PresidentSep 09Option Exercise159.3260095,59218,206Sep 10 05:15 PM
HERTIA JOHNExecutive Vice PresidentSep 09Sale336.47444149,39317,762Sep 10 05:15 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 08Option Exercise0.00400014,563Sep 09 06:27 PM
STARK JAMES RVP, Corporate ControllerSep 07Option Exercise0.003000626Sep 09 03:45 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 07Option Exercise0.0050001,257Sep 09 05:08 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 07Option Exercise0.0060003,395Sep 09 05:17 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 07Option Exercise0.0060002,517Sep 09 05:36 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 07Option Exercise0.003,0000278,809Sep 10 02:04 PM
HERTIA JOHNExecutive Vice PresidentSep 07Option Exercise0.00600017,904Sep 09 05:50 PM
HUTTON RONALD WVice President and TreasurerSep 07Option Exercise0.0017004,430Sep 09 06:11 PM
HERTIA JOHNExecutive Vice PresidentSep 06Option Exercise164.477,2001,184,15422,499Sep 09 05:50 PM
HERTIA JOHNExecutive Vice PresidentSep 06Sale336.575,1951,748,49017,304Sep 09 05:50 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 06Sale340.00371126,1401,917Sep 09 05:36 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 05Option Exercise0.0060002,496Sep 09 05:36 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 05Option Exercise0.0060003,003Sep 09 05:17 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 05Option Exercise0.005000930Sep 09 05:08 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 05Option Exercise0.002,6000416,472Sep 09 03:49 PM
STARK JAMES RVP, Corporate ControllerSep 05Option Exercise0.003000430Sep 09 03:45 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 05Option Exercise0.00500014,411Sep 09 03:40 PM
HUTTON RONALD WVice President and TreasurerSep 05Option Exercise0.0018004,323Sep 09 06:11 PM
HERTIA JOHNExecutive Vice PresidentSep 05Option Exercise0.00600015,507Sep 09 05:50 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 04Option Exercise0.0060002,611Sep 05 02:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 04Option Exercise0.005000603Sep 05 02:04 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 04Option Exercise0.0060002,104Sep 05 02:52 PM
HERTIA JOHNExecutive Vice PresidentSep 04Option Exercise0.00600015,115Sep 05 05:26 PM
STARK JAMES RVP, Corporate ControllerSep 04Option Exercise0.002000200Sep 05 02:22 PM
SCHWARTZ NORMAN DChairman, President and CEOSep 04Option Exercise0.002,6000415,162Sep 05 02:17 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 04Option Exercise0.00500014,117Sep 05 02:11 PM
HUTTON RONALD WVice President and TreasurerSep 04Option Exercise0.0018004,206Sep 05 02:07 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 04Sale333.081,089362,7232,011Sep 05 02:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecAug 14Sale320.0031099,200103Aug 14 05:51 PM
Crowley MichaelEVP, GBL Commercial OperationsAug 14Sale320.00325104,0003,100Aug 14 05:46 PM